We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BEAM market cap is 2.64B. The company's latest EPS is USD -4.5013 and P/E is -6.33.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 316.19M | 7.41M | 11.77M | 14.27M | 30.07M |
| Operating Income | 132.86M | -104.13M | -104.9M | -106.5M | -100.04M |
| Net Income | 142.8M | -98.67M | -91.05M | -96.67M | -90.32M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 24k | 51.84M | 60.92M | 377.71M | 63.52M |
| Operating Income | -132.76M | -392.47M | -318.28M | -176.49M | -415.57M |
| Net Income | -194.59M | -370.64M | -289.09M | -132.53M | -376.7M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.46B | 1.36B | 1.26B | 1.17B | 1.1B |
| Total Liabilities | 478.39M | 446.31M | 407.17M | 380.05M | 370.28M |
| Total Equity | 981.33M | 913.49M | 854.09M | 791.32M | 733.55M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 451.68M | 1.47B | 1.34B | 1.46B | 1.1B |
| Total Liabilities | 206.12M | 647.72M | 608.24M | 478.39M | 370.28M |
| Total Equity | 245.56M | 826.74M | 733.47M | 981.33M | 733.55M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -149.2M | -99.75M | -182.76M | -270.88M | -347.25M |
| Investing | 71.84M | -53.46M | 34.03M | 58.73M | 185.01M |
| Financing | 276.45M | 2.9M | 3.03M | 4.29M | 7.74M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -95.74M | -66.27M | 22.53M | -149.2M | -347.25M |
| Investing | -100.12M | -294.14M | -461.34M | 71.84M | 185.01M |
| Financing | 322.32M | 756.14M | 111.59M | 276.45M | 7.74M |
| Market Cap | 2.64B |
| Price to Earnings Ratio | -6.33 |
| Price to Sales Ratio | 37.52 |
| Price to Cash Ratio | 8.45 |
| Price to Book Ratio | 3.25 |
| Dividend Yield | - |
| Shares Outstanding | 83.69M |
| Average Volume (1 week) | 1.54M |
| Average Volume (1 Month) | 1.56M |
| 52 Week Change | -15.04% |
| 52 Week High | 38.40 |
| 52 Week Low | 20.84 |
| Spread (Intraday) | 0.56 (1.75%) |
| Company Name | Beam Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.beamtx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
